Medpace is a full service clinical research organisation providing Phase I to IV clinical development services to biopharmaceutical and medical device companies. The company integrates trial services through wholly owned laboratories, imaging core labs, and a Phase I unit. This single vendor approach minimises duplication, maintains continuity, and accelerates regulatory approval pathways.
Trusted predominantly by small to midsize biotech clients, Medpace embeds cross functional teams of medical, regulatory, and operational experts into each trial. The company specialises in complex studies across major disease areas, leveraging 30 years of organic growth and global site relationships to deliver high quality results efficiently.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
6200
Team Members
1992
Founded
Contract Research
Sector
Hybrid
Work Environment
Our Vision
A world where safe and effective medical therapeutics reach patients faster through seamlessly executed clinical research.
Our Mission
Medpace's mission is to accelerate the global development of safe and effective medical therapeutics.